Marx Biotechnology

Develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD).

Health Tech & Life Sciences
Active
Seed Jerusalem, Israel Founded 2011
Last updated 2026-07-26
Total raised
$645K
Last: Grant 2019-09
Stage
Seed
Founded
2011
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Marx Biotechnology is a Jerusalem-based startup focused on developing diagnostic and pharmaceutical products. Their primary product is a blood test for the early diagnosis of Graft-versus-host disease (GVHD), which aims to save lives, reduce costs, and improve patient care by allowing for quick, accurate, and efficient treatment decisions. The company's technology analyzes the GSK-3β molecule to identify abnormalities linked to various diseases. They have completed animal trials and a pilot project on humans and are looking to raise a Series A funding round. Marx Biotechnology (MBT) has two patents that are in the final stages and a third pending in Israel. MBT has also submitted a Pre-IDE to the FDA and received an NSR letter, allowing them to proceed with a discovery trial.

Funding history · 3 rounds · $645K total

2019-08
Grant $50K
2019-05
Seed Undisclosed
2014-02
Pre-Seed $595K

Headcount over time

From 5 (2018-09) to 2 (2025-05) · -3 (-60%) · 12 points · source: Finder history + radar grounding
60 2018-09 2025-05

Q&A

What is Marx Biotechnology's primary focus?
Marx Biotechnology (MBT) develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD) to improve patient care and reduce costs.
How many employees does Marx Biotechnology have?
Marx Biotechnology has 1-10 employees.
When was Marx Biotechnology founded?
Marx Biotechnology was founded in January 2011.
What is Marx Biotechnology's total funding to date?
Marx Biotechnology has raised a total of $1,215,000 USD.
When was Marx Biotechnology's most recent funding round?
Marx Biotechnology's most recent funding round was a Grant in September 2019, with EU Horizon 2020 as an investor.
Who is the founder and CEO of Marx Biotechnology?
Stephen Marx Ph.D. is the Founder & CEO of Marx Biotechnology.
What is the product stage of Marx Biotechnology's offerings?
Marx Biotechnology's product is currently in the R&D stage.
Does Marx Biotechnology hold any patents?
Yes, Marx Biotechnology holds 1 patent.

Team · 1

Stephen G. Marx
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicesdiagnosticsantibodieshospitalslaboratoriesdoctorsbiotechnologybiomarkersbig-datablood-testinflammatory-diseasesnon-invasivecancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemarxbio.com
LinkedInlinkedin.com/company/2495418
YouTubeyoutube.com/channel/UCGv_j6ERjIYtKsp6J2SWZWQ

Identifiers & details

Founded2011-1
Employees (exact)2

Radar intelligence

Web history (Wayback)

Domainmarxbio.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514545912
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2011-01-04
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressעלית הנוער 4 ירושלים